May. 11 at 12:11 PM
$XBI BREAKING!!!
Fractyl Health,
$GUTS, has been authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes
This is massive folks.
$GUTS also has landmark pivotal data coming this year for their weight loss retention treatment.
#1 Bio in our portfolio, and for good reason. If you don't know about Fractyl (
$GUTS) yet, this might be a good time to start taking a look.
Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn.
Let's make some (more) money. Cheers!
$LLY $NVO $PFE